Evidence map›Paper›PMID 33822446›Full record

ArticleDiabetes, obesity & metabolism2021

Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study.

Samah Hayek, Yatir Ben-Shlomo, Ran Balicer, Katherine Byrne, Mark Katz, Eldad Kepten, Itamar Raz, Eytan Roitman, Marcin Zychma, Noam Barda

Abstract readLetter
In one paragraph

Article in Diabetes, obesity & metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Is single point HbA1c a reliable predictor for death in severe COVID-19?Journal of preventive medicine and hygiene · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samah HayekClalit Research Institute, Clalit Health Services, Ramat Gan, Israel.ORCID 0000-0002-3300-1769
Yatir Ben-ShlomoClalit Research Institute, Clalit Health Services, Ramat Gan, Israel.
Ran BalicerClalit Research Institute, Clalit Health Services, Ramat Gan, Israel.
Katherine ByrneNovo Nordisk International Operations, Zürich, Switzerland.
Mark KatzClalit Research Institute, Clalit Health Services, Ramat Gan, Israel.
Eldad KeptenClalit Research Institute, Clalit Health Services, Ramat Gan, Israel.
Itamar RazDiabetes Medical Center, Tel-Aviv, Israel.
Eytan RoitmanClalit Research Institute, Clalit Health Services, Ramat Gan, Israel.
Marcin ZychmaNovo Nordisk International Operations, Zürich, Switzerland.
Noam BardaClalit Research Institute, Clalit Health Services, Ramat Gan, Israel.ORCID 0000-0002-3400-235X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Diabetes Mellitus, Type 2Blood GlucoseCohort StudiesGlycated HemoglobinGlycemic ControlHumansHypoglycemic AgentsRetrospective StudiesSARS-CoV-2Severity of Illness IndexBlood GlucoseGlycated HemoglobinHypoglycemic Agents

Identifiers

PMID33822446
PMCPMC8251473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.